• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Development and Use of Diagnostic Testing

Video

Bryan Loy, MD, discusses how the FDA approval process for emerging diagnostic tests is becoming more rigorous and well defined. He notes that this guidance should be of help in theplanning stages of test development. Dr Loy explains that many of these tests are being developed in the laboratory industry rather than the pharmaceutical industry. He insists that innovation should not be stifled, and that it is in everyone’s interest to move tests quickly through the approval process to market while ensuring their validity.

Dr Loy is uncertain about how well providers really understand the development process, or in some cases, even the quality, the analytic validity, and the methodology of those tests. Therefore, adoption will be based on a variety of factors including price point, accessibility, decentralization, interpretability of the information, ease of doing business, and ability to return results fast enough to avoid delaying therapy.


Related Videos
Will Shapiro
Mila Felder, MD, FACEP
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS)
Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance (COA) and physician and partner of AO Multispecialty Clinic in Augusta, Georgia.
Dr Lucy Langer
Edward Arrowsmith, MD, MPH
Dr Kathi Mooney
Tiago Biachi de Castria, MD, PhD, Moffitt Cancer Center
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.